|
|
LIFE SCIENCES AND HEALTHCARE
With increased pressure on costs, competition, and regulation, the healthcare environment is undergoing a seismic shift. Proactive Worldwide’s Life Sciences team has the business, industry, and scientific expertise to provide the contextual insight and perspective to optimize your business decisions.
[ EVIDENCE-BASED DECISION SUPPORT FOR THE
ENTIRE CLINICAL AND COMMERCIAL SPECTRUM ]
|
Strategic intelligence grounded in a foundation of evidence-based practices adds immense value to a company’s competitive health. Intelligence obtained through these methods acts as a sophisticated diagnostic detection tool—in the same way that a blood test or MRI reveals unique information below the surface that may not emerge for some time.
We understand the changes and challenges of the competitive healthcare landscape in all its complexity:
|
- Corporate strategy
- Legal and regulatory environment
- Insurance and managed care
- Pricing
- Contracting
- Marketing
- Sales force structure
- Manufacturing capabilities
- Technology and medical education
- Medical and scientific developments
- Logistics management
- Personalized medicine
- Evidence-based medicine and marketing
- Globalization and emerging markets
- Cost economics
- Generics and patent expiry
- R&D pipeline
|
Our Capabilities and Areas of Expertise
|
PWW assists our clients with making evidence-based decisions in the following therapeutic areas:
|
- Oncology and hematology
- Central nervous system
- Infectious diseases
- Cardiovascular
- Pain and inflammation
- Endocrine and diabetes
- Respiratory
- Gastroenterology
- Dermatology
|
|
Our decision support products, programs, and services focus on these industry segments:
|
- Pharmaceuticals – brand, generic, Rx-OTC
- Biotechnology – brand, biosimilar, orphan drugs and rare diseases
- Medical devices and diagnostic systems
- Medication delivery systems
- Consumer care – OTC
- Nutraceuticals – dietary supplements and nutritionals
- Animal health
|
|
We conduct customized programs to meet client needs in every phase of the compound and brand lifecycle:
|
- Pre-clinical and clinical – Phases I-III
- Commercialization
- Extension – Phase IV
- Pharmacoeconomics
- Evidence-based medicine
|
|
To meet this need for flexibility and customization, we offer the following services:
|
- Conference monitoring
- Generic threat assessments and scans
- Biosimilar threat assessments and scans
- Multicultural marketing assessments
- Orphan and rare diseases planning
- Business development scans
- Early warning planning
- Product launch-threat assessment
|
|
